Inventor · disambiguated record
Sergio G. Duron
Also filed as: DURON SERGIO · DURON SERGIO G · DURÓN SERGIO · DURÓN SERGIO G
27 granted patents·48 pending applications·226 citations·filing 2004–2024
96Inventor score
Top patents by PatentIndex Score
75 records- 0198US8399018B2Controlled release ion channel modulator compositions and methods for the treatment of otic disordersLICHTER JAY·Filed 2009·Granted Mar 19, 2013·49 cites·18 claims
- 0297US8846770B2Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disordersLICHTER JAY·Filed 2009·Granted Sep 30, 2014·33 cites·6 claims
- 0397US8784870B2Controlled release compositions for modulating free-radical induced damage and methods of use thereofLICHTER JAY·Filed 2009·Granted Jul 22, 2014·35 cites·9 claims
- 0497US8496957B2Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disordersLICHTER JAY·Filed 2009·Granted Jul 30, 2013·29 cites·13 claims
- 0595US9427472B2Controlled release compositions for modulating free-radical induced damage and methods of use thereofOTONOMY INC·Filed 2014·Granted Aug 30, 2016·13 cites·15 claims
- 0692US11548892B1Transglutaminase 2 (TG2) inhibitorsSITARI PHARMA INC·Filed 2022·Granted Jan 10, 2023·4 cites·6 claims
- 0792US7517884B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2006·Granted Apr 14, 2009·11 cites·10 claims
- 0891US10272034B2Auris formulations for treating otic diseases and conditionsOTONOMY INC·Filed 2015·Granted Apr 30, 2019·7 cites·8 claims
- 0989US9333171B2Controlled-release CNS modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2014·Granted May 10, 2016·7 cites·15 claims
- 1089US2024358634A1Auris formulations for treating otic diseases and conditionsDOMPE FARM SPA·Filed 2024·Application pending·0 cites
- 1186US10232044B2Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disordersOTONOMY INC·Filed 2014·Granted Mar 19, 2019·3 cites·16 claims
- 1286US10092580B2Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disordersLICHTER JAY·Filed 2009·Granted Oct 9, 2018·8 cites·3 claims
- 1383US8680082B2Controlled release corticosteroid compositions and methods for the treatment of otic disordersLICHTER JAY·Filed 2011·Granted Mar 25, 2014·3 cites·9 claims
- 1482US10501493B2Broad spectrum antibioticsRQX PHARMACEUTICALS INC·Filed 2016·Granted Dec 10, 2019·2 cites·19 claims
- 1582US8680083B2Controlled release corticosteroid compositions and methods for the treatment of otic disordersLICHTER JAY·Filed 2011·Granted Mar 25, 2014·3 cites·8 claims
- 1682US7494999B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2005·Granted Feb 24, 2009·6 cites·9 claims
- 1779US8674095B2Compounds for treating neuropsychiatric conditionsCAMPBELL DAVID·Filed 2009·Granted Mar 18, 2014·4 cites·7 claims
- 1879US2022040096A1Auris formulations for treating otic diseases and conditionsOTONOMY INC·Filed 2021·Application pending·0 cites
- 1978US2025011324A1Transglutaminase 2 (tg2) inhibitorsSITARI PHARMA INC·Filed 2024·Application pending·0 cites
- 2077US10918594B2Controlled-release CNS modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2019·Granted Feb 16, 2021·0 cites·20 claims
- 2177US8372970B28-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disordersAFRAXIS INC·Filed 2010·Granted Feb 12, 2013·4 cites·15 claims
- 2276US8680099B26-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disordersCAMPBELL DAVID·Filed 2011·Granted Mar 25, 2014·2 cites·55 claims
- 2375US8912203B26-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disordersCAMPBELL DAVID·Filed 2011·Granted Dec 16, 2014·1 cites·32 claims
- 2474US2021220263A1Controlled-release cns modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2021·Application pending·0 cites
- 2572US2010016450A1Controlled release delivery devices for the treatment of otic disordersOTONOMY INC·Filed 2009·Application pending·0 cites
- 2671US7834004B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2008·Granted Nov 16, 2010·1 cites·37 claims
- 2769US10227314B2Cystathionine-gamma-lyase (CSE) inhibitorsSOVA PHARMACEUTICALS INC·Filed 2017·Granted Mar 12, 2019·1 cites·9 claims
- 2869US2009325938A1Controlled-release cns modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2009·Application pending·0 cites
- 2967US2025353926A1Crosslinking multispecific antibodiesENLAZA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3065US2018110727A1Controlled release corticosteroid compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2017·Application pending·0 cites
- 3165US2010016218A1Controlled-release apoptosis modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2009·Application pending·0 cites
- 3264US12152026B2Transglutaminase 2 (TG2) inhibitorsSITARI PHARMA INC·Filed 2019·Granted Nov 26, 2024·0 cites·27 claims
- 3363US2025136564A1Protein tyrosine phosphatase inhibitors and uses thereofNERIO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3463US2019192425A1Controlled release delivery devices for the treatment of otic disordersOTONOMY INC·Filed 2019·Application pending·0 cites
- 3563US2025134882A1Protein tyrosine phosphatase inhibitors and uses thereofNERIO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3662US2009227599A1Sulfonyl-substituted bicyclic compounds as modulators of pparKALYPSYS INC·Filed 2009·Application pending·0 cites
- 3762US2025129032A1Protein tyrosine phosphatase inhibitors and uses thereofNERIO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3861US2016228357A1Auris Formulations for Treating Otic Diseases and ConditionsOTONOMY INC·Filed 2016·Application pending·0 cites
- 3960US11969501B2Auris formulations for treating otic diseases and conditionsDOMPE FARM SPA·Filed 2021·Granted Apr 30, 2024·0 cites·20 claims
- 4060US2025257059A1Protein tyrosine phosphatase inhibitors and uses thereofNERIO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4160US2016310415A1Controlled release compositions for modulating free-radical induced damage and methods of use thereofOTONOMY INC·Filed 2016·Application pending·0 cites
- 4259US7915253B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2008·Granted Mar 29, 2011·0 cites·40 claims
- 4359US2017000728A1Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic DisordersOTONOMY INC·Filed 2016·Application pending·0 cites
- 4459US2013150410A1Controlled Release Ion Channel Modulator Compositions and Methods for the Treatment of Otic DisordersOTONOMY INC·Filed 2013·Application pending·0 cites
- 4559US2019298799A1Controlled-release apoptosis modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2019·Application pending·0 cites
- 4653US2014364430A1Methods for treating schizophreniaAFRAXIS HOLDINGS INC·Filed 2014·Application pending·0 cites
- 4751US9771339B2Cystathionine-γ-lyase (CSE) inhibitorsSOVA PHARMACEUTICALS INC·Filed 2013·Granted Sep 26, 2017·0 cites·15 claims
- 4851US9725426B2Cystathionine-γ-lyase (CSE) inhibitorsSOVA PHARMACEUTICALS INC·Filed 2013·Granted Aug 8, 2017·0 cites·19 claims
- 4951US2010317715A1Methods for treating neuropsychiatric conditionsVOLLRATH BENEDIKT·Filed 2008·Application pending·0 cites
- 5050US2016199446A1Controlled-release apoptosis modulating compositions and methods for the treatment of otic disordersOTONOMY INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →